Home › Atrial Fibrillation › Florida › Boca Raton
Atrial Fibrillation clinical trials in Boca Raton, FL
4 studies for Atrial Fibrillation are looking for participants at sites in and around Boca Raton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
RecruitingPhase 3
- Excel Medical Clinical Trials, dba Flourish Research, Boca Raton
BOdygUardian MOnitoriNg for ReCurrencE of AF
RecruitingObservational study
- Arrhythmia Center of South Florida, Delray Beach · 7 mi away
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
RecruitingPhase 3
- Anthos Investigative Site 1013, Boca Raton
Tracking Results of Ablations to Combat AF Registry Generation 2
RecruitingObservational study
- Delray Medical Center, Delray Beach · 7 mi away
About Atrial Fibrillation
Atrial fibrillation (AF or AFib) is the most common type of arrhythmia (irregular heartbeat). Read about symptoms and treatment.
More about Atrial Fibrillation on MedlinePlus
Atrial Fibrillation trials in other cities
- Boston, MA19 studies
- New York City, NY19 studies
- Atlanta, GA17 studies
- Cleveland, OH17 studies
- Jonesboro, AR13 studies
- Pittsburgh, PA12 studies
- Philadelphia, PA12 studies
- Ann Arbor, MI12 studies
- Chicago, IL12 studies
- Orlando, FL11 studies
- Cincinnati, OH10 studies
- Austin, TX10 studies
Other studies in Boca Raton
- Parkinson's Disease11 studies
- Alzheimer's Disease8 studies
- Myasthenia Gravis8 studies
- Obesity7 studies
- Type 2 Diabetes7 studies
- Overweight6 studies
- High Blood Pressure6 studies
- Heart Failure6 studies
- Breast Cancer4 studies
- Non-Small Cell Lung Cancer4 studies
- Schizophrenia4 studies
- Chronic Kidney Disease4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.